TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Eilean Therapeutics
Eilean Therapeutics
University of Turin, Italy
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Washington University School of Medicine
Brigham and Women's Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS